产品详情

  • 产品名称：SARS CoV-2 Spike Glycoprotein South Africa variant Blocking Peptide for STJ506305 peptide (South Africa variant) (STJ506306)

  • 产品型号：STJ506306-250
  • 产品厂商：ST john's laboratory
  • 产品文档：
你添加了1件商品 查看购物车
简单介绍：
SARS CoV-2 Spike Glycoprotein South Africa variant Blocking Peptide for STJ506305 peptide (South Africa variant) (STJ506306)
详情介绍：
Applications: Immunodepletion/Immunocompetition
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: SARS CoV-2 Spike Glycoprotein South Africa variant Blocking Peptide for STJ506305 is synthetically produced from the 400-450 sequence about the South Africa variant and is suitable for use in western blot applications.
Formulation: Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice.
Storage Instruction: Store at-20°C for long term storage. Avoid freeze-thaw cycles.
Immunogen Region: 400-450
Specificity: This blocking peptide is recommended for use in combination with SARS CoV-2 Spike Glycoprotein South Africa variant antibody, STJ506305
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
姓名：
电话：
您的需求：
 
网站地图